Adjuvant Chemotherapy for Stage III Colon Cancer

SIMPLE SUMMARY: In patients with stage III colon cancer, adjuvant chemotherapy with a fluoropyrimidine combined with oxaliplatin reduces the risk of recurrence and mortality, with a treatment duration that may be shortened from 6 to 3 months in certain situations allowing to limit toxicities, especi...

Descripción completa

Detalles Bibliográficos
Autores principales: Taieb, Julien, Gallois, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564362/
https://www.ncbi.nlm.nih.gov/pubmed/32961795
http://dx.doi.org/10.3390/cancers12092679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564362/
https://www.ncbi.nlm.nih.gov/pubmed/32961795
http://dx.doi.org/10.3390/cancers12092679

Ejemplares similares